Evidence-based recommendations on regorafenib (Stivarga) for previously treated metastatic colorectal cancer in adults.
Commercial arrangement
There is a simple discount patient access scheme for regorafenib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS or...
Evidence-based recommendations on nivolumab (Opdivo) with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma.
Commercial arrangement
There is a commercial arrangement for nivolumab. NHS organisations can get...
Evidence-based recommendations on upadacitinib (Rinvoq) for treating active non-radiographic axial spondyloarthritis in adults.
Commercial arrangement
There is a simple discount patient access scheme for upadacitinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. N...
Evidence-based recommendations on somatrogon (Ngenla) for treating growth disturbance in children and young people aged 3 years and over....
Shi, Chen;
Fan, Bifa;
Miao, Liyan;
Chen, Xiao;
Dai, Haibin;
Xu, Ting;
Liu, Jinmei;
Luo, Min;
Yao, Difei;
Sun, Bao;
Hu, Can;
Zhao, Ming;
Zhu, Changyu;
Li, Qian;
Zhang, Yu.
Topical non-steroidal anti-inflammatory drugs (NSAIDs) are one of the primary drugs for treating musculoskeletal pain. However, there are currently no evidence-based recommendations about drug selection, drug administration, drug interactions, and use in special populations or other pharmacology-related ...
Kim, Tae-Han;
Kim, In-Ho;
Kang, Seung Joo;
Choi, Miyoung;
Kim, Baek-Hui;
Eom, Bang Wool;
Kim, Bum Jun;
Min, Byung-Hoon;
Choi, Chang In;
Shin, Cheol Min;
Tae, Chung Hyun;
Gong, Chung Sik;
Kim, Dong Jin;
Cho, Arthur Eung-Hyuck;
Gong, Eun Jeong;
Song, Geum Jong;
Im, Hyeon-Su;
Ahn, Hye Seong;
Lim, Hyun;
Kim, Hyung-Don;
Kim, Jae-Joon;
Yu, Jeong Il;
Lee, Jeong Won;
Park, Ji Yeon;
Kim, Jwa Hoon;
Song, Kyoung Doo;
Jung, Minkyu;
Jung, Mi Ran;
Son, Sang-Yong;
Park, Shin-Hoo;
Kim, Soo Jin;
Lee, Sung Hak;
Kim, Tae-Yong;
Bae, Woo Kyun;
Koom, Woong Sub;
Jee, Yeseob;
Kim, Yoo Min;
Kwak, Yoonjin;
Park, Young Suk;
Han, Hye Sook;
Nam, Su Youn;
Kong, Seong-Ho.
Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this is the 4th gastric cancer guideline published in Korea which is the revised version of previous evidence-based approach in 2018. Current guideline is a collaborative work of the interdisciplinary working group inclu...
Qaseem, Amir;
Hicks, Lauri;
Etxeandia-Ikobaltzeta, Itziar;
Shamliyan, Tatyana;
Cooney, Thomas G;
Cross, J. Thomas;
Fitterman, Nick;
Lin, Jennifer S;
Maroto, Miguel;
Obley, Adam J;
Tice, Jeffrey A;
Tufte, Janice.
Osteoporosis is a disease, common in older age, that makes your bones weaker and can lead to a fracture. People with previous fractures and those who have other risk factors for fractures, including family history of fractures, vitamin D deficiency or low calcium intake, smoking, excessive alcohol intake...
Evidence-based recommendations on maribavir (Livtencity) for cytomegalovirus infection in adults after transplant.
Commercial arrangement
There is a simple discount patient access scheme for maribavir. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisat...
NICE is unable to make a recommendation on angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock. This is because Paion AG did not provide an evidence submission. We will review this decision if the company decides to make a submission....
Evidence-based recommendations on lenvatinib (Kisplyx) with pembrolizumab (Keytruda) for untreated advanced renal cell carcinoma in adults.
Commercial arrangements
There is a simple discount patient access scheme for lenvatinib and a commercial access agreement for pembrolizumab. NHS organisations can g...
